Yield10 Addresses Application of Metabolic Engineering to Increase Crop Yield in Paper Published in Plant Science
April 26 2018 - 8:30AM
Chief Science Officer Kristi
Snell also confirmed as a keynote speaker at
upcoming plant
meeting
Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company developing new
technologies to create step-change improvements in crop yield to
enhance global food security, today highlighted upcoming events in
the form of a scientific research paper published in Plant Science,
a leading peer-reviewed scientific journal, as well an upcoming
presentation at a plant conference in late April. Both
opportunities are a result of Yield10’s innovative approach to
engineering gene traits designed to increase crop yield, and the
Company’s status as a leading voice and thought leader in the
agricultural innovation sector.
The paper, entitled “Metabolic Engineering to Increase Crop
Yield: From Concept to Execution,” is authored by Yield10
employees and leadership including Frank A. Skraly, Madana
M.R. Ambavaram, Oliver Peoples, and Kristi D. Snell, and is part of
a special issue of Plant Science, an international journal of
experimental plant biology. It discusses how trait discovery
programs can benefit from smart approaches that incorporate
predictive models to identify novel gene targets to increase yields
in key crops. The paper references Yield10’s own trait discovery
program, and examines various external factors that impact the cost
and timeline to reach commercialization.
On April 28, Chief Science Officer Kristi Snell, Ph.D., will
present as one of the keynote speakers at the Northeast Section of
The American Association of Plant Biologists (ASPB) 2018 meeting,
held at the University of Massachusetts (UMASS), Amherst. At the
meeting, she will discuss how step-change increases in crop yield
will require innovators to build better plants. Snell will discuss
the Company’s multifaceted approach to discovering gene targets
that boost plant productivity, including the use of in silico
analyses of plant metabolism and gene networks. Yield10 relies on
targeted design strategies for plant metabolic engineering, as
opposed to the mass screening and trial-and-error approaches that
have stagnated the development in this sector within the crop
industry for the past 20 years.
“We are pleased to participate in these opportunities to
demonstrate and discuss how we apply our unique metabolic
engineering skill sets to increase crop yield,” said Kristi Snell,
Chief Science Officer at Yield10 Bioscience, Inc. “We believe our
trait discovery programs, which incorporate targeted rational
design strategies with genome editing tools, are a clear
differentiator from existing industry approaches, and will continue
to serve as the basis for our research and scientific
collaborations with leading universities and agtech companies.”
About Yield10
Bioscience
Yield10 Bioscience, Inc. is focused on developing new
technologies to achieve step-change improvements in crop yield to
enhance global food security. Yield10 has an extensive track record
of innovation based around optimizing the flow of carbon in living
systems. Yield10 is leveraging its technology platforms and
unique knowledge base to design precise alterations to gene
activity and the flow of carbon in plants to produce higher yields
with lower inputs of land, water or fertilizer. Yield10 is
advancing several yield traits it has developed in crops such as
Camelina, canola, soybean and rice. Yield10 is headquartered in
Woburn, MA and has an Oilseeds center of excellence in Saskatoon,
Canada.
For more information about the company, please visit
www.yield10bio.com.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, the use of technology to successfully identify targets
for increasing crop yield, the formation of new collaborations and
progress by Yield10, constitute forward-looking statements. Such
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results to differ materially
from those anticipated, including the risks and uncertainties
detailed in Yield10 Bioscience's filings with the Securities and
Exchange Commission. Yield10 assumes no obligation to update any
forward-looking information contained in this press release or with
respect to the matters described herein.
Contacts: Yield10
Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Amato and Partners,
LLCadmin@amatoandpartners.com
Media Inquiries: Eric FischgrundFischtank Marketing and
PReric@fischtankpr.com
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024